Picture of Oxford Nanopore Technologies logo

ONT Oxford Nanopore Technologies Income Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual income statement for Oxford Nanopore Technologies, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue114134199170183
Cost of Revenue
Gross Profit46.973.212490.5105
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses187299299338336
Operating Profit-73.1-166-101-168-153
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-73.2-166-83.4-150-140
Provision for Income Taxes
Net Income After Taxes-61.2-168-91-155-146
Net Income Before Extraordinary Items
Net Income-61.2-168-91-155-146
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-61.2-168-91-155-146
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.075-0.228-0.123-0.183-0.157
Dividends per Share